SCHEMBL873998

SCHEMBL873998

O=C(O)C(=O)CC(=O)c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.62
ERCC5 P28715 4/20 0.60
FEN1 P39748 4/20 0.60
PTPN1 P18031 2/20 0.60
TDP1 Q9NUW8 1/20 0.60
HAO1 Q9UJM8 3/20 0.58
CES1 P23141 2/20 0.57
CA1 P00915 2/20 0.55
CA2 P00918 2/20 0.55
CES2 O00748 1/20 0.55
SRD5A2 P31213 1/20 0.55
HSD11B1 P28845 1/20 0.54
TSHR P16473 1/20 0.53
ALDH1A1 P00352 1/20 0.53
MAPK1 P28482 1/20 0.53
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11510574 0.88 GSK3B (0.71) GSK3BTDP1CES1CA1CA2
SCHEMBL7208394 0.87 GSK3B (0.65) GSK3BTDP1CES1CA1CA2
SCHEMBL9207986 0.85 CES1 (0.70) GSK3BTDP1CES1CES2HSD11B1
SCHEMBL279440 0.81 MAPK1 (0.63) GSK3BTDP1CES1CA1CA2
SCHEMBL6756989 0.81 TSHR (0.63) GSK3BTDP1CES1CA1CA2
SCHEMBL29291733 0.81 MEN1 (0.58) GSK3BTDP1CES1CA1CA2
SCHEMBL1699076 0.81 GSK3B (0.57) GSK3BTDP1CES1CA1CA2
SCHEMBL240086 0.80 GSK3B (0.71) GSK3BTDP1CES1CA1CA2
SCHEMBL27601084 0.80 TSHR (0.61) GSK3BTDP1CES1CA1CA2
SCHEMBL18302433 0.80 TP53 (0.65) ERCC5FEN1PTPN1CES1CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012038904-A1 NICOTINAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-03-29 WO disclosed
WO-2012038905-A1 THIENOPYRIDINE NICOTINAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-03-29 WO disclosed